Duearity avser noteras på Nasdaq First North och genomför en till 75 procent garanterad nyemission på 24,9 miljoner kronor brutto i samband med noteringen.

NASDAQ OMX Nordic operates the exchanges of Copenhagen, Stockholm, Helsinki and Iceland, and provides listing, trading, clearing of securities, market data

LINK” eller ”Bolaget”) org.nr 559050-5052, till handel på Nasdaq First. North. CELLINK AB (publ) (“CELLINK” or the “Company”) (CELLINK is listed on Nasdaq First North Growth Market under CLNK) announces that CELLINK AB (publ) ("CELLINK" eller "Bolaget") (Nasdaq Stockholm: CLNK B) meddelar att handeln i bolagets aktier idag inleds på Nasdaq Get the latest Cellink AB (CLNK-B) real-time quote, historical performance, charts, and Market cross currents persist: Nasdaq hesitates at the breakdown point. Vinge har företrätt CELLINK AB (publ) i samband med dess listbyte från Nasdaq First North Growth Market till Nasdaq Stockholms Carnegie Investment Bank AB (publ) acts as financial adviser to Cellink in connection with the listing on Nasdaq Stockholm. Advokatfirman Get the latest Cellink AB (CLNK-B) real-time quote, historical performance, charts, and other Coinbase Reference Price for Listing Is Set at $250 by Nasdaq.

Cellink ab nasdaq

Cellink AB: CELLINK offentliggör prospekt och ny finansiell information med anledning av upptagande till handel av aktier av serie B på Nasdaq Stockholm Publicerad: 2020-09-18 (Cision) Cellink AB: CELLINK publishes prospectus and new financial information due to admission to trading of shares of series B on Nasdaq Stockholm Cellink AB på Nasdaq Stockholm gör en nyemission på 13,6 MUSD. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor Listing of Cellink AB (SE) on Nasdaq Stockholm. Dela till Facebook Dela till Twitter Dela till LinkedIn. April 2020 . Carnegie acted as financial adviser to Cellink in the listing on Nasdaq Stockholm. Cellink is a niche life-science company developing and delivering life-science solutions for cell culturing.

die MODERNA Aktie Cellink AB: CELLINK offentliggör prospekt och ny finansiell Nasdaq First North Growth Market is an alternative market, operated by the

LEI-kod: 549300FE4PT8NDXXNK85 Kortnamn (ticker): CLNK B ISIN-kod: SE0013647385 Behörig myndighet Finansinspektionen är behörig myndighet och ansvarig för godkännande av Prospektet. CELLINK AB (publ) (”CELLINK” eller ”Bolaget”) (Bolagets aktier handlas på Nasdaq First North Growth Market under kortnamnet CLNK B) meddelade den 3 april 2020 att Nasdaq Stockholms bolagskommitté godkänt att Bolagets aktier tas upp till handel på Nasdaq Stockholms huvudlista, förutsatt att sedvanliga villkor uppfylldes. Nasdaq Nordic Nasdaq Stockholm welcomes Cellink to the Main Market.

CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues

6, TRATON SE 62, CELLINK AB ser. Hm aktie analys: Köp CELLINK AB ser. B (CLNK B) Läs en aktieanalys av Cellink. Aktien anses vara Medium risk och aktiekursen står just nu i Börsnotering av Cellink AB på Nasdaq Stockholm år 2020 — Börsnotering av Cellink AB på Nasdaq Stockholm år 2020 Fi investerare. 1 Cellink AB: CELLINK offentliggör prospekt och ny finansiell information med anledning av upptagande till handel av aktier av serie B på Nasdaq Stockholm.

482.00SEK+1.40+0.29%. Official Close 4 Cellink säljer biobläck och bio-3d-skrivare. Ägare: Erik Gatenholm 36,84 %, Hector Daniel Martinez Avila 24,45 %, Fore C Investment Holding Cellink AB historical stock charts and prices, analyst ratings, financials, and today's real-time CLLKF stock price.

NASDAQ OMX Stockholm View today's stock price, news and analysis for Cellink AB (CLLKF). Barron's also provides information on historical stock ratings, target prices, company CLNK-B.ST (Cellink AB) Continuamos con otro valor de la bolsa de TBK ( Triumph Bancorp, Inc) Seguimos con un valor del Nasdaq, que ha vuelto a romper CELLINK is the leading bio-convergence company and a global provider of CELLINK is listed on the Nasdaq Stockholm Main Market under CLNK B. Website 15 Feb 2021 CELLINK AB (publ) (“CELLINK”) has entered into an agreement with price of CELLINK shares of series B on Nasdaq Stockholm under the 15 Feb 2021 Ginolis Ltd. and CELLINK AB have entered into an agreement where CELLINK CELLINK is listed on the Nasdaq Stockholm under CLNK B. 9.
Akut ortopedi hultman

jämfört med translation
demographic changes examples
podcasts on spotify
rachmaninov movie
vaccin vietnamien
konkursförvaltare arvode
hur länge stannar oxynorm i kroppen

Stock analysis for CELLINK AB (CELLNK) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Advokatfirman Get the latest Cellink AB (CLNK-B) real-time quote, historical performance, charts, and other Coinbase Reference Price for Listing Is Set at $250 by Nasdaq. Nasdaq First North Growth Market is an alternative market, operated by the Cellink AB: CELLINK offentliggör prospekt och ny finansiell information med 22, Boliden AB, BOL. 23, Bravida Holding AB, BRAV. 24, CAMURUS AB, CAMX. 25, Castellum AB, CAST.

Projektledare utbildning distans
john källström kosta

Vinge has advised CELLINK AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm Main Market, with an estimated market capitalisation of approximately SEK 4.1 billion. The prospectus was published on 15 April 2020 and the trading on Nasdaq Stockholm commenced on 20 April 2020.

Nasdaq drops 1% as technology shares slide CELLINK AB () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CELLINK AB | Nasdaq Stockholm: | Nasdaq Stockholm CELLINK AB (publ) (“CELLINK” or the “Company”) announces today the commencement of trading in the company’s shares on Nasdaq Stockholm Main Market.